Acrongenomics Inc.

Acrongenomics Inc.

Acrongenomics Inc. (OTCBB: AGNM), is a publicly traded company, specializing in the field of Molecular Diagnostics by integrating nanotechnology with molecular biology, the so called Nano-JETA platform. Companys latest achievements include the completion of its unique and unsurpassed Neo-EpCAM Cancer detection kit which overcomes all known problems arising from conventional PCR, ELISA and Real Time PCR. The unparalleled technology used has been proven via extended validated studies in HER1, HER2, HER3, HER4, p53, vEGF as well as HPV, EBV, and HBV.

Acrongenomics technology exhibits the following key features:

Absence of buffer or buffer systems
No need for calibration
Optional use of MgCl2
Results can be achieved up to ten times quicker compared to all other PCR, and Real Time PCR kits currently available to the market.
Substantial reduction in reagent amount needed to perform PCR and Real Time PCR tests.
Absence of contamination
Compatible to all known conventional PCR and Real Time PCR equipment.
Ease of use - no expertise personnel is required to perform the tests.
Lack of competition

Company Details

Company Information

Tom Skarpelos
Title: Manager
Telephone: (514) 285-6428
Email: Click Here

Products

Ep-cam Detection Kit

Services